Otsuka Holdings
Otsuka Holdings is the Japanese holding company of the Otsuka Group, whose businesses include pharmaceuticals, functional beverages and foods, medical devices, chemicals, and logistics.
Last updated October 16, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Otsuka Holdings is a Japanese holding company that oversees the Otsuka Group. The group traces its origins to 1921, when Otsuka Pharmaceutical Factory was founded in Tokushima Prefecture. Otsuka Holdings itself was established in 2008 as a new parent company, with the stated aim of strengthening management across the group. Its role is to coordinate and manage a portfolio of operating companies rather than to represent a single product line. The group’s activities span pharmaceuticals and other health-related businesses, as well as functional beverages and foods. The official company describes its purpose as supporting people’s lives worldwide through a broad range of innovative products and services. The group also encompasses medical-device, chemical, food, and logistics companies. Its named core operating companies include Otsuka Pharmaceutical, Otsuka Pharmaceutical Factory, Taiho Pharmaceutical, Otsuka Warehouse, Otsuka Chemical, Otsuka Foods, and Otsuka Medical Devices. The group’s corporate philosophy is “Otsuka-people creating new products for better health worldwide.” The company says its approach draws on the principles of “sweat, enlightenment,” verification, and creativity, and emphasizes making products and services that contribute to health and everyday life. Its stated markets are global, while the supplied evidence does not specify a complete country-by-country footprint. Otsuka Holdings listed in Tokyo in December 2010. It is a constituent of major Japanese market indices according to the supplied Japanese Wikipedia entry, and it moved to the Tokyo Stock Exchange’s Prime Market in April 2022. The company continues to present itself as the management and corporate center of a diversified health-oriented group, publishing investor materials, group information, sustainability updates, and news from its operating companies.
History
The Otsuka Group’s history begins in 1921, when Otsuka Pharmaceutical Factory was founded in Tokushima Prefecture. The group expanded over subsequent decades through the creation and addition of businesses in pharmaceuticals, chemicals, and food. The supplied Japanese Wikipedia account records Otsuka Chemical’s establishment in 1950, Taiho Pharmaceutical’s establishment in 1963, and the establishment of Otsuka Pharmaceutical in 1964. It also records the addition of CBC Food Industry, later renamed Otsuka Food Industry and then Otsuka Foods, to the group in the 1960s and its later renaming in 1989. Before the holding-company structure, ownership and management of group companies were organized in different ways, including periods when Otsuka Pharmaceutical Factory held much of the equity in group companies and periods of reciprocal shareholdings. In 2008, the group established Otsuka Holdings as a new parent company through a share transfer by Otsuka Pharmaceutical. The stated purpose was to strengthen management of the group as a whole. During the same year, the holding company took on share-management responsibilities and brought key companies, including Otsuka Pharmaceutical Factory, Otsuka Warehouse, and Taiho Pharmaceutical, under its corporate structure. The supplied history describes subsequent steps to make several of these companies wholly owned subsidiaries. In 2009, Otsuka Holdings brought Otsuka Chemical Holdings into the group, later making it wholly owned and changing its name to Otsuka Chemical after it absorbed the operating company. Otsuka Holdings completed its initial public listing on the Tokyo Stock Exchange on 15 December 2010. In 2011, it established Otsuka Medical Devices as a direct subsidiary and transferred medical-device-related share-management responsibilities to it. The group’s structure has continued to include distinct operating companies across pharmaceuticals, medical devices, food, chemicals, and logistics. In 2014, Otsuka Pharmaceutical, a subsidiary, acquired Avanir Pharmaceuticals, which became a consolidated subsidiary in January 2015. The supplied account also records the transfer of a medical-device business to Otsuka Medical Devices in 2018, the direct placement of Otsuka Foods under Otsuka Holdings in the same year, and the transfer of shared-services operations to Otsuka Business Support in 2019. Otsuka Holdings entered the Tokyo Stock Exchange Prime Market on 4 April 2022, following the exchange’s market restructuring. The group presents its shared philosophy as “Otsuka-people creating new products for better health worldwide.” Its official materials describe a continuing focus on innovative pharmaceuticals, functional beverages, functional foods, and a broad portfolio of products and services intended to support people’s lives. The official history page frames the group’s story as a century-long development from its origins and directs readers to individual operating companies for more detailed company histories.
- 2022
Moved to the Tokyo Stock Exchange Prime Market
- 2019
Shared-services business transferred to Otsuka Business Support
- 2018
Otsuka Foods became a direct subsidiary
- 2015
Avanir Pharmaceuticals became a consolidated subsidiary
- 2014
Otsuka Pharmaceutical announced the acquisition of Avanir Pharmaceuticals
- 2011
Otsuka Medical Devices established as a direct subsidiary
- 2010
Listed on the Tokyo Stock Exchange First Section
- 2009
Otsuka Chemical Holdings brought into the group and made wholly owned
- 2008
Otsuka Holdings established as a new parent company
- 2008
Group restructuring brought key operating companies under Otsuka Holdings
Products and positioning
A diversified Japanese holding company centered on health-related businesses, guided by a stated commitment to creating products for better health worldwide.
Pharmaceuticals
A core group business delivered through operating companies including Otsuka Pharmaceutical, Otsuka Pharmaceutical Factory, and Taiho Pharmaceutical.
Functional beverages and foods
Health-oriented product categories identified in the group’s official corporate philosophy and business description.
Medical devices
A group business represented by Otsuka Medical Devices.
Chemical products
A group business represented by Otsuka Chemical.
Brand decisions
- Adopted a holding-company structure to strengthen management across the groupOther
- Changed the fiscal year-end to align with overseas consolidated subsidiariesOther
Sources6 sources
Cite this profile: Cite the canonical profile. /brand-wiki/otsuka-holdings · Editorial policy · How profiles are compiled